SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-064244
Filing Date
2023-08-08
Accepted
2023-08-08 08:12:04
Documents
49
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0623_cormedix.htm   iXBRL 10-Q 1052371
2 CERTIFICATION f10q0623ex31-1_cormedix.htm EX-31.1 10983
3 CERTIFICATION f10q0623ex31-2_cormedix.htm EX-31.2 10934
4 CERTIFICATION f10q0623ex32-1_cormedix.htm EX-32.1 3453
5 CERTIFICATION f10q0623ex32-2_cormedix.htm EX-32.2 3561
  Complete submission text file 0001213900-23-064244.txt   4818745

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE crmd-20230630.xsd EX-101.SCH 40376
7 XBRL CALCULATION FILE crmd-20230630_cal.xml EX-101.CAL 32477
8 XBRL DEFINITION FILE crmd-20230630_def.xml EX-101.DEF 185344
9 XBRL LABEL FILE crmd-20230630_lab.xml EX-101.LAB 373683
10 XBRL PRESENTATION FILE crmd-20230630_pre.xml EX-101.PRE 193030
43 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623_cormedix_htm.xml XML 721980
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34673 | Film No.: 231149432
SIC: 2834 Pharmaceutical Preparations